Experiment 487957
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | BRAQUET,P:. (1993). CEDEMIN, A GINKGO BILOBA EXTRACT, SHOULD NOT BE CONSIDERED AS A PAF ANTAGONIST.. 88(12) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN CLINICAL STUDIES PERFORMED WITH THE MOST POTENT GINKGOLIDE, BN52021(GINKGOLIDE B), 120 TO 240 MG/KG DAILY DOSES ARE REQUIRED TO OBTAIN PAF ANTAGONIST EFFECTS. |
| Dose amount | VAR |
| Number | 2 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Extract | ETOH(30%)EXT |